PPD® Biotech

Finance Forward: Biotech's Opportunity-Rich Financing Landscape

Join PPD® Biotech for an engaging discussion on today’s opportunity-rich biotech financing landscape for Bay Area biotechnology companies. Our after-work networking reception will be followed by a panel discussion with interactive audience Q&A, moderated by John Carroll, editor of Endpoints News.

Marriott Waterfront San Francisco Airport

1800 Old Bayshore Highway, Burlingame, CA 94010
Thursday, 20 September 2018 | 5:30-8 p.m. PDT

This roundtable will feature some of the keenest minds in biotech and venture capital. Don’t miss this exciting opportunity to network, share expertise and learn from key players in the Bay Area biotech ecosystem.

The panelists include:

  • Neil Kumar, Ph.D., Chief Executive Officer, BridgeBio Pharma
  • Robert McDowell, Ph.D., Chief Scientific Officer, MyoKardia, Inc.
  • Paul Scansaroli, Managing Director, Barclays Equity Capital Markets
  • Sujal Shah, President and Chief Executive Officer, CymaBay Therapeutics, Inc.
  • Sandy Zweifach, President and Chief Executive Officer, Nuvelution Pharma, Inc.

Please fill out the following form to RSVP

Pharmaceutical Product Development, LLC and its affiliates (together “PPD”) may use the information you provide on this page for the purpose of contacting you on this subject. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.

About PPD Biotech

PPD® Biotech is devoted to finding the right Phase I-IV clinical development solutions for biotech and small to midsize pharma companies. We offer dedicated resources across clinical operations, medical operations and a full set of support functions.


PPD Biotech
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2020 PPD, Inc. All Rights Reserved.